Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Becker, William Leschensky, and Francis Lunger

Premium

Christopher Becker has been promoted to the position of vice president, chemistry, for SurroMed.

Becker joined SurroMed in 2001 as director of chemistry. Prior to this, he was senior director of proteomic technology at Thermo Electron, and earlier, a staff scientist with SRI International. He conducted his postdoctoral work in chemistry and physics at Massachusetts Institute of Technology, and received his PhD in chemistry from University of California, Berkeley.

SurroMed has also promoted William Leschensky to the position of vice president of intellectual property. He joined the company in 2000 as director of intellectual property and has served as associate general counsel. Prior to this, he was an associate at the law firm of Fish & Neave. He received his MD from the University of Illinois and a law degree from Harvard Law School.


Millipore has announced that Francis Lunger, chairman of the board, president, and CEO, has decided to step down as president and CEO upon the naming of his replacement before March 1, 2005. Lunger will continue to remain chairman of the board for a period of time after his successor is named.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.